EU Pushes For Compulsory Licensing Of Drugs & Vaccines In Health Crises

Activists Welcome 'Surprise' Move But Industry Disappointed

The EU has published an action plan that is intended to upgrade the bloc’s intellectual property framework while ensuring that goods such as medicines and vaccines are made as widely available as possible. The initiative is part of wide-ranging plans to support member states’ recovery from the pandemic crisis and help ensure the EU’s resilience to future health threats.

Intellectual Property text on colorful broken background
The EU is planning significant changes in the IP area • Source: Shutterstock

In a move that has angered the R&D-based pharmaceutical industry, the European Commission has called on EU member states to take coordinated action on the issuing of compulsory licenses for therapeutics and vaccines in the event of future health crises such as COVID-19, albeit as a “last resort” when other efforts to make the intellectual property available have failed.

In its intellectual property action plan, the commission says that the COVID-19 crisis “has illustrated EU’s dependence on critical innovations...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography